Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Introduction: Identifying clinical measures that track disease in the earliest stages of frontotemporal lobar degeneration (FTLD) is important for clinical trials. Familial FTLD provides a unique paradigm to study early FTLD. Executive dysfunction is a clinically relevant hallmark of FTLD and may be a marker of disease progression. Methods: Ninety‐three mutation carriers with no symptoms or minimal/questionable symptoms (MAPT, n = 31; GRN, n = 28; C9orf72, n = 34; Clinical Dementia Rating scale plus NACC FTLD Module < 1) and 78 noncarriers enrolled through Advancing Research and Treatment in Frontotemporal Lobar Degeneration/Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects studies completed the Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research (NIH‐EXAMINER) and the UDS neuropsychological battery. Linear mixed‐effects models were used to identify group differences in cognition at baseline and longitudinally. We examined associations between cognition, clinical functioning, and magnetic resonance imaging volumes. Results: NIH‐EXAMINER scores detected baseline and differences in slopes between carriers and noncarriers, even in carriers with a baseline Clinical Dementia Rating scale plus NACC FTLD Module = 0. NIH‐EXAMINER declines were associated with worsening clinical symptoms and brain volume loss. Discussion: The NIH‐EXAMINER is sensitive to cognitive changes in presymptomatic familial FTLD and is a promising surrogate endpoint.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationTwo Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Self-citationThe heritability and genetics of frontotemporal lobar degeneration
Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536
Self-citationDevelopment of methodology for conducting clinical trials in frontotemporal lobar degeneration
Knopman, D. S., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N. (2008) · Brain · doi:10.1093/brain/awn234 · Cited by 442
Self-citationBapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
Vandenberghe, R., Rinne, J. O., Boada, M., Katayama, S., Scheltens, P., Vellas, B., Tuchman, M., Gass, A., Fiebach, J. B., Hill, D., et al. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0189-7 · Cited by 304
Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
Staffaroni, A. M., Ljubenkov, P. A., Kornak, J., Cobigo, Y., Datta, S., Marx, G., Walters, S. M., Chiang, K., Olney, N., Elahi, F. M., et al. (2019) · Brain · doi:10.1093/brain/awy319 · Cited by 105
Self-citationMeta-analytic review of memory impairment in behavioral variant frontotemporal dementia
Poos, J. M., Jiskoot, L. C., Papma, J. M., van Swieten, J. C., & van den Berg, E. (2018) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718000115 · Cited by 57
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
Staffaroni, A. M., Cobigo, Y., Goh, S. M., Kornak, J., Bajorek, L., Chiang, K., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.04.007 · Cited by 40
Self-citation
Research works printed but not linked: 24
- 10.1126/scitranslmed.3007941 · DOI · Paper page
- 10.1038/547153a · DOI · Paper page
- 10.1111/jnc.13640 · DOI · Paper page
- Mansoor Y, 2014, Memory Profiles in Pathology or Biomarker Confirmed Alzheimer Disease and Frontotemporal Dementia, Alzheimer Dis Assoc Disord, 29, 135, 10.1097/WAD.0000000000000062 · DOI · Paper page
- 10.1097/00146965-200312000-00002 · DOI · Paper page
- Patel AN, 2015, Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis, Curr Neurol Neurosci Rep, 15, 59, 10.1007/s11910-015-0582-9 · DOI
- 10.1212/WNL.0b013e318296e940 · DOI · Paper page
- 10.1177/0891988717700507 · DOI
- 10.1016/S1353-8020(02)00098-6 · DOI
- 10.1002/ana.10024 · DOI · Paper page
- 10.1017/S1355617713001094 · DOI · Paper page
- Weintraub S, 2017, Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS), Alzheimer Dis Assoc Disord, 1
- 1944, Army Individual Test Battery Manual of Directions and Scoring
- Delis DC, 2000, California Verbal Learning Test - second edition. Adult version. Manual
- 10.1016/j.jalz.2016.10.006 · DOI · Paper page
- Sakpal TV, 2010, Sample size estimation in clinical trial, Perspect Clin Res, 1, 67, 10.4103/2229-3485.71856 · DOI · Paper page
- Possin KL, 2018, Ecological Validity and Neuroanatomical Correlates of the NIH EXAMINER Executive Composite Score, J Int Neuropsychol Soc, 20, 20, 10.1017/S1355617713000611 · DOI · Paper page
- Hambleton RK, 1991, Fundamentals of Item Response Theory
- 10.1037/0894-4105.17.3.380 · DOI · Paper page
- 10.1212/WNL.0000000000002895 · DOI · Paper page
- 10.1007/s00415-018-8850-7 · DOI · Paper page
- 10.1017/S1355617712000823 · DOI
- 10.1017/S1355617714000551 · DOI · Paper page
- 10.1111/jnc.13654 · DOI · Paper page
Cited by
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Staffaroni, A. M., Quintana, M., Wendelberger, B., Heuer, H. W., Russell, L. L., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Petrucelli, L., Gendron, T. F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01942-9 · Cited by 140
Self-citationSynaptic Loss in Frontotemporal Dementia Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Malpetti, M., Jones, P. S., Cope, T. E., Holland, N., Naessens, M., Rouse, M. A., Rittman, T., Savulich, G., Whiteside, D. J., Street, D., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26543 · Cited by 53
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration
Casaletto, K. B., Staffaroni, A. M., Wolf, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto‐Reilly, K., Elahi, F. M., Fields, J., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12001 · Cited by 48
Self-citationUniform data set language measures for bvFTD and PPA diagnosis and monitoring
Staffaroni, A. M., Weintraub, S., Rascovsky, K., Rankin, K. P., Taylor, J., Fields, J. A., Casaletto, K. B., Hillis, A. E., Lukic, S., Gorno‐Tempini, M. L., et al. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12148 · Cited by 33
Self-citationRecognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia
Barker, M. S., Manoochehri, M., Rizer, S. J., Appleby, B. S., Brushaber, D., Dev, S. I., Devick, K. L., Dickerson, B. C., Fields, J. A., Foroud, T. M., et al. (2021) · Cortex · doi:10.1016/j.cortex.2021.03.006 · Cited by 29
Self-citation
Metadata
- Authors
- Staffaroni, A. M., Bajorek, L., Casaletto, K. B., Cobigo, Y., Goh, S. M., Wolf, A., Heuer, H. W., Elahi, F. M., Ljubenkov, P. A., Dever, R., Kornak, J., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., Brushaber, D., Caso, C., Coppola, G., Dheel, C., Dickerson, B. C., Dickinson, S., Dominguez, S., Domoto‐Reilly, K., Faber, K., Ferrall, J., Fields, J. A., Fishman, A., Fong, J., Foroud, T., Forsberg, L. K., Gavrilova, R., Gearhart, D., Ghazanfari, B., Ghoshal, N., Goldman, J., Graff‐Radford, J., Graff‐Radford, N., Grant, I., Grossman, M., Haley, D., Hsiung, G., Huey, E. D., Irwin, D. J., Jones, D. T., Jones, L., Kantarci, K., Karydas, A., Kaufer, D. I., Kerwin, D. R., Knopman, D. S., Kraft, R., Kremers, W. K., Kukull, W. A., Litvan, I., Lucente, D., Lungu, C., Mackenzie, I. R., Maldonado, M., Manoochehri, M., McGinnis, S. M., McKinley, E., Mendez, M. F., Miller, B. L., Multani, N., Onyike, C., Padmanabhan, J., Pantelyat, A., Pearlman, R., Petrucelli, L., Potter, M., Rademakers, R., Ramos, E. M., Rankin, K. P., Rascovsky, K., Roberson, E. D., Rogalski, E., Sengdy, P., Shaw, L. M., Syrjanen, J., Tartaglia, M. C., Tatton, N., Taylor, J., Toga, A., Trojanowski, J. Q., Weintraub, S., Wang, P., Wong, B., Wszolek, Z., Boxer, A. L., Boeve, B. F., Kramer, J. H., Rosen, H. J., & on behalf of the ARTFL/LEFFTDS consortium
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 16
- Issue
- 1
- Pages
- 11-21
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2944460071
- Cited by
- 47
- References
- 9
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- Funders
- National Institutes of Health (AG045390)
- Larry L. Hillblom Foundation
- Centers for Disease Control and Prevention
- Bristol-Myers Squibb
- Pfizer
- Wyeth
- Huntington's Disease Society of America
- New York State Department of Health (1510130358)
- Biogen
- AbbVie
- Canadian Institutes of Health Research
- Alzheimer Society of B.C.
- BrightFocus Foundation
- Alzheimer's Drug Discovery Foundation
- Roche
- Genentech
- Eisai
- University of Southern California
- AstraZeneca
- U.S. Department of Defense
- Parkinsonfonden
- Michael J. Fox Foundation for Parkinson's Research
- Janssen Pharmaceuticals
- Merck
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- Allergan
- Association for Frontotemporal Degeneration
- Alzheimer's Association
- GE Healthcare
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. https://app.cochat.ai/papers/10.1016/j.jalz.2019.01.012
- The paper
- Staffaroni, A. M., Bajorek, L., Casaletto, K. B., Cobigo, Y., Goh, S. M., Wolf, A., Heuer, H. W., Elahi, F. M., Ljubenkov, P. A., Dever, R., Kornak, J., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., Brushaber, D., Caso, C., Coppola, G., Dheel, C., . . . on behalf of the ARTFL/LEFFTDS consortium. (2020). Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2019.01.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.